美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tao Synergies Inc.

8.35

+0.50006.37%

盘后：7.83-0.5200-6.23%19:59 EDT

成交量：72.53万

成交额：551.20万

市值：1,160.50万

市盈率：-0.84

高：8.61

开：7.45

低：6.10

收：7.85

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Tao Synergies Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.synaptogen.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Synaptogenix, Inc.于2012年10月31日在特拉华州注册成立。该公司是一家生物制药公司，拥有处于临床前和临床开发阶段的候选产品。该公司主要专注于开发基于一种名为Bryostatin-1的候选药物的产品平台，该药物由从海洋无脊椎动物生物体中分离出来的天然产物（bryostatin）合成，用于治疗阿尔茨海默病（“AD”），该药物正处于临床测试阶段。

董事

名称

职位

Joshua Silverman

Executive Chairman of the Board

William S. Singer

Vice Chairman of the Board

Alan J. Tuchmam

Chief Medical Officer,Director

Bruce T. Bernstein

Independent Director

Jonathan L. Schechter

Independent Director

股东

名称

职位

Robert Weinstein

Chief Financial Officer, Secretary and Executive Vice President

Alan J. Tuchmam

Chief Medical Officer,Director

Joshua Silverman

Executive Chairman of the Board

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/TAOX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAOX\",,,,,undefined,":{"symbol":"TAOX","market":"US","secType":"STK","nameCN":"Tao Synergies Inc.","latestPrice":8.35,"timestamp":1751400000000,"preClose":7.85,"halted":0,"volume":725327,"hourTrading":{"tag":"盘后","latestPrice":7.83,"preClose":8.35,"latestTime":"19:59 EDT","volume":17820,"amount":144288.3277,"timestamp":1751414342046},"delay":0,"floatShares":1380701,"shares":1389815,"eps":-9.900128,"marketStatus":"已收盘","change":0.5,"latestTime":"07-01 16:00:00 EDT","open":7.45,"high":8.61,"low":6.1,"amount":5511951.359328,"amplitude":0.319745,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.900128,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1751443200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":7.85,"preHourTrading":{"tag":"盘前","latestPrice":7.25,"preClose":7.85,"latestTime":"09:27 EDT","volume":84215,"amount":705251.1065799999,"timestamp":1751376473524},"postHourTrading":{"tag":"盘后","latestPrice":7.83,"preClose":8.35,"latestTime":"19:59 EDT","volume":17820,"amount":144288.3277,"timestamp":1751414342046},"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAOX\",,,,,undefined,":{"symbol":"TAOX","floatShares":1380701,"roa":"--","roe":"--","lyrEps":-10.990077,"shares":1389815,"dividePrice":0,"high":8.61,"amplitude":0.319745,"preClose":7.85,"low":6.1,"week52Low":1.84,"pbRate":"--","week52High":8.61,"institutionHeld":0,"latestPrice":8.35,"eps":-9.900128,"divideRate":0,"volume":725327,"delay":0,"ttmEps":-9.900128,"open":7.45,"prevYearClose":3.47,"prevWeekClose":6.045,"prevMonthClose":7.85,"prevQuarterClose":7.85,"fiveDayClose":4,"twentyDayClose":2.675,"sixtyDayClose":2.27},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.synaptogen.com","compareEarnings":[{"period":"1week","weight":0.0295},{"period":"1month","weight":0.0483},{"period":"3month","weight":0.1014},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.1353},{"period":"ytd","weight":0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Synaptogenix, Inc.于2012年10月31日在特拉华州注册成立。该公司是一家生物制药公司，拥有处于临床前和临床开发阶段的候选产品。该公司主要专注于开发基于一种名为Bryostatin-1的候选药物的产品平台，该药物由从海洋无脊椎动物生物体中分离出来的天然产物（bryostatin）合成，用于治疗阿尔茨海默病（“AD”），该药物正处于临床测试阶段。","exchange":"NASDAQ","name":"Tao Synergies Inc.","nameEN":"Tao Synergies Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TAOX\",market:\"US\",,,undefined,":{"directors":[{"name":"Joshua Silverman","position":"Executive Chairman of the Board"},{"name":"William S. Singer","position":"Vice Chairman of the Board"},{"name":"Alan J. Tuchmam","position":"Chief Medical Officer,Director"},{"name":"Bruce T. Bernstein","position":"Independent Director"},{"name":"Jonathan L. Schechter","position":"Independent Director"}],"executives":[{"name":"Robert Weinstein","position":"Chief Financial Officer, Secretary and Executive Vice President"},{"name":"Alan J. Tuchmam","position":"Chief Medical Officer,Director"},{"name":"Joshua Silverman","position":"Executive Chairman of the Board"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAOX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAOX\",market:\"US\",delay:false,,,undefined,":{}}}